OR51E2/PSGR activation with β-ionone has been shown to inhibit cell proliferation12 and prostate tumor xenografts expressing PSGR generate larger tumors in mice compared to normal prostate tumors13. This evidence concerns the gene OR51E2 and prostate neoplasm.